Portal de investigación
COST MINIMIZATION ANALYSIS OF RITUXIMAB BIOSIMILAR VERSUS REFERENCE RITUXIMAB IN THE TREATMENT OF FOLLICULAR LYMPHOMA
Fecha de publicación:
Autores de IIS La Fe
Participantes ajenos a IIS La Fe
- Gironella, M.
- Gallardo-Escudero, J.
- Gomez-Barrera, M.
- Becares Martinez, F. J.
- Martinez-Sesmero, J. M.
- Oyaguez, I
Grupos
Abstract
Abstract no disponible
Filiaciones
Filiaciones no disponibles
Campos de Estudio
Cita
Gironella,M,Gallardo,J,Gomez,M,Jarque,I,Becares,FJ,Poveda,JL,Martinez,JM et al. COST MINIMIZATION ANALYSIS OF RITUXIMAB BIOSIMILAR VERSUS REFERENCE RITUXIMAB IN THE TREATMENT OF FOLLICULAR LYMPHOMA. 61st National Congress of the Spanish-Society-of-Hematology-and-Hemotherapy. 2019. Valencia. VIA GIUSEPPE BELLI 4, 27100 PAVIA, ITALY:FERRATA STORTI FOUNDATION. 2019 p.p. 93-93.